Parexel VPs Discuss COVID-19, RWE, and New Challenges
Parexel’s Leanne Larson and Matthew Gordon shared their thoughts on the growing importance of real world evidence (RWE) in clinical [...]
Parexel’s New Organization Aims to Bolster Clinical Development
In a bid to optimize clinical development, Parexel has launched its new Regulatory & Access consulting organization consisting of more [...]
The problem with the GVD…
Almost all companies with a product in development will develop a global value dossier (GVD) to support launch. Every product [...]
Advertisement
